- Home
- ITRN vs CVAC Comparison
ITRN vs CVAC Comparison
Compare ITRN & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRN
- CVAC
- Stock Information
- Founded
- ITRN 1994
- CVAC 2000
- Country
- ITRN Israel
- CVAC Germany
- Employees
- ITRN N/A
- CVAC 1088
- Industry
- ITRN Electronic Components
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- ITRN Technology
- CVAC Health Care
- Exchange
- ITRN Nasdaq
- CVAC Nasdaq
- Market Cap
- ITRN 783.6M
- CVAC 1.2B
- IPO Year
- ITRN 2005
- CVAC 2020
- Fundamental
- Price
- ITRN $39.76
- CVAC $5.45
- Analyst Decision
- ITRN Buy
- CVAC Hold
- Analyst Count
- ITRN 1
- CVAC 3
- Target Price
- ITRN $50.00
- CVAC $6.83
- AVG Volume (30 Days)
- ITRN 88.1K
- CVAC 2.3M
- Earning Date
- ITRN 08-18-2025
- CVAC 08-14-2025
- Dividend Yield
- ITRN 4.99%
- CVAC N/A
- EPS Growth
- ITRN 10.62
- CVAC N/A
- EPS
- ITRN 2.77
- CVAC 0.87
- Revenue
- ITRN $337,686,000.00
- CVAC $566,039,775.00
- Revenue This Year
- ITRN $10.31
- CVAC N/A
- Revenue Next Year
- ITRN $9.63
- CVAC $24.04
- P/E Ratio
- ITRN $14.22
- CVAC $6.30
- Revenue Growth
- ITRN 3.73
- CVAC 787.60
- 52 Week Low
- ITRN $24.78
- CVAC $2.37
- 52 Week High
- ITRN $45.43
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- ITRN 65.45
- CVAC 63.45
- Support Level
- ITRN $38.70
- CVAC $5.36
- Resistance Level
- ITRN $39.87
- CVAC $5.51
- Average True Range (ATR)
- ITRN 1.00
- CVAC 0.07
- MACD
- ITRN 0.24
- CVAC -0.05
- Stochastic Oscillator
- ITRN 78.53
- CVAC 66.67
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.